More than ever, marketers and agencies have a powerful role in shaping public health, curbing harmful behaviors, and promoting good ones among at-risk communities and individuals.
Today's effective communicators must be comfortable with change, learn how to anticipate it, and adapt messaging to key audiences.
Recently, Forbes ran an article from Wild Pixel Media founder and CEO Carlos Machicao lamenting the fact that healthcare advertising is boring.
Acquisitions that were applauded a few years ago, such as Teva's purchase of Allergan's generic business, now look like lemons.
The EVP of global and emerging markets at rbb Communications dishes on how best to communicate with patients.
Purdue's decision to pull OxyContin sales reps highlights what has been the biggest part of marketing budgets. Did we just see the tipping point?
For some, the term machine learning may conjure up images of virtual assistants or automated tools.
For Brands to Play a Meaningful Role in People's Lives, Pharma Needs to Rethink Its Marketing Playbook
Let's accept there is work to be done and ask with justifiable optimism: Why have pharma brands not yet cracked the code?
By allowing companies to claim a 50% tax credit for qualified clinical testing expenses, developing drugs for rare diseases became economically feasible for the first time.
At a time when value-based healthcare is a more common objective among stakeholders, EHR data can enable collaboration among payers, providers, health systems, and pharma manufacturers.